What’s My Fertility at CHR
An Innovative fertility risk screening for young women
Dr. Norbert Gleicher introduces What’s My Fertility, a risk screening program for young women to avoid future infertility due to premature ovarian aging (POA).
Why What’s My Fertility?
What’s My Fertility is an innovative infertility risk screening program available completely online and based on a patented algorithm developed by the physicians and scientists at CHR. What’s My Fertility screens young women (ages 18-35) for future risk of developing premature ovarian aging (POA). POA affects about 10% of all women and can lead to infertility that often requires extensive treatments to overcome. Because POA is a silent condition without obvious symptoms, women with POA often do not know they have this condition, and diagnosis may come as a complete surprise.
With What’s My Fertility, young women can now learn whether they are at risk of POA, and at-risk women can take appropriate action before the condition becomes a clinical problem. Early detection of POA risk gives young women more reproductive options, which are far more effective and less costly than extensive infertility treatments later in life.
Getting Started with What's My Fertility
What’s My Fertility is a great starting point for women who would like to one day have a child with their own eggs and:
- Have a family history of POA or infertility
- Are considering egg freezing or other fertility preservation methods
- Are simply curious about their future fertility prognosis
This program is available online to women in some states in the United States and around the world. For more information about using the What's My Fertility process online, our How It Works page has more details about what's involved.
If What’s My Fertility screening is not available online in your state, you can also consult CHR physicians for an evaluation of your current and future fertility, honest advice on egg freezing and other aspects of fertility-planning.
Read more about Whats My Fertility at CHR
Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned specialist in reproductive endocrinology, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.